Medical marijuana
Medical marijuana or medical cannabis refers to the use of cannabis or derivatives of cannabis plants to treat medical illnesses or reduce symptoms.[1] Medical marijuana typically contains both CBD and THC, which are two of the many biologically active substances found in cannabis.[2][3] CBD, which is not intoxicating or addictive, can also be produced from hemp plants, and is often marketed as CBD oil and sold legally as a without needing a perscription.[1][citation needed]
Evidence[edit | edit source]
A review by Whiting et al. (2015) found moderate evidence that medical use of cannabis can help with chronic pain, but this review did not look at pain in ME/CFS.[4]
Limited evidence is available for the use of cannabis or medical marijuana in people with fibromyalgia.[5][6]
Notable studies[edit | edit source]
- 2011, Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life[5]
- 2015, Cannabinoids for medical use: A systematic review[4]
- 2016, Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.[8]
- 2019, An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia[6]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 "Definition of MEDICAL MARIJUANA". Merrian-Webster Dictionary. Retrieved April 11, 2019.
- ↑ "Definition of THC". Merrian-Webster Dictionary. Retrieved April 11, 2019.
- ↑ "Definition of CBD". Merrian-Webster Dictionary. Retrieved April 11, 2019.
- ↑ 4.0 4.1 4.2 Whiting, Penny F.; Wolff, Robert F.; Deshpande, Sohan; Di Nisio, Marcello; Duffy, Steven; Hernandez, Adrian V.; Keurentjes, J. Christiaan; Lang, Shona; Misso, Kate (June 23, 2015). "Cannabinoids for Medical Use". JAMA. 313 (24): 2456. doi:10.1001/jama.2015.6358. ISSN 0098-7484.
- ↑ 5.0 5.1 Farré, Magí; Carbonell, Jordi; Capellà, Dolors; Durán, Marta; Fiz, Jimena (April 21, 2011). "Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life". PLOS ONE. 6 (4): e18440. doi:10.1371/journal.pone.0018440. ISSN 1932-6203. PMC 3080871. PMID 21533029.
- ↑ 6.0 6.1 van de Donk, Tine; Niesters, Marieke; Kowal, Mikael A.; Olofsen, Erik; Dahan, Albert; van Velzen, Monique (April 2019). "An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia". PAIN. 160 (4): 860. doi:10.1097/j.pain.0000000000001464. ISSN 0304-3959.
- ↑ Ryan, Duncan; Drysdale, Alison J.; Lafourcade, Carlos; Pertwee, Roger G.; Platt, Bettina (February 18, 2009), "Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels", The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29 (7): 2053–2063, doi:10.1523/JNEUROSCI.4212-08.2009, ISSN 1529-2401, PMID 19228959
- ↑ Jadoon, Khalid A.; Ratcliffe, Stuart H.; Barrett, David A.; Thomas, E. Louise; Stott, Colin; Bell, Jimmy D.; O’Sullivan, Saoirse E.; Tan, Garry D. (August 29, 2016), "Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study", Diabetes Care: American Diabetes Association, 39 (10): 1777–86, doi:10.2337/dc16-0650